Why is Akums Drugs falling/rising?

As of 11-Sep, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 461.00, which reflects a decrease of Rs 8.1 or 1.73%. The stock has underperformed its sector by 2.2% today, with an intraday low of Rs 458.5. Over the past week, the stock has seen a decline of 1.04%, and its year-to-date performance shows a significant drop of 27.75%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 32.84% compared to the 5-day average. While the company has a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.4, it has also reported poor long-term growth, with net sales growing at an annual rate of only 6.10% over the last five years.
In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 1.03% over the past week and 4.36% year-to-date. This underperformance is further highlighted by the stock's returns, which have been negative across multiple time frames, including a staggering 49.36% decline over the past year. The company's flat results in June, including a 21.6% drop in profit after tax compared to the previous quarter, and the lowest operating profit to interest ratio at 5.57 times, contribute to the negative sentiment surrounding the stock. Overall, the combination of poor financial performance, declining investor interest, and unfavorable comparisons to the broader market suggests that Akums Drugs is facing significant challenges that are driving its stock price lower.